Centenial Surgical Suture Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 191360, "name": "Centenial Surgic", "stock_name": "Centenial Surgic", "full_name": "Centenial Surgical Suture Ltd", "name_url": "stocks-analysis/centenial-surgic", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "77.00", "chg": -1.5, "chgp": "-1.91%", "dir": -1, "prev_price": "78.50", "mcapval": "28.00 Cr", "mcap": "Micro Cap", "scripcode": 531380, "symbol": "", "ind_name": "Healthcare Services", "ind_code": 94, "indexname": "India SENSEX", "isin": "INE405H01018", "curr_date": "Mar 27", "curr_time": "", "bse_nse_vol": "106 ", "exc_status": "Active", "traded_date": "Mar 27, 2026", "traded_date_str": "2026 03 27", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/centenial-surgic-191360-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Centenial Surgical Suture Ltd Falls to 52-Week Low of Rs 77 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/centenial-surgical-suture-ltd-falls-to-52-week-low-of-rs77-amidst-continued-downtrend-3919964", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CentenialSurgic_priceRelatedfactors_3919964.png", "date": "2026-03-27 14:37:22", "description": "For the fourth consecutive session, Centenial Surgical Suture Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 77 on 27 Mar 2026. This marks a significant 59.2% drop from its 52-week high of Rs 189, underscoring persistent selling pressure despite pockets of operational improvement." }, { "title": "Five Consecutive Losses Push Centenial Surgical Suture Ltd to a New 52-Week Low", "link": "https://www.marketsmojo.com/news/stocks-in-action/centenial-surgical-suture-ltd-falls-to-52-week-low-of-rs773-3915634", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CentenialSurgic_priceRelatedfactors_3915634.png", "date": "2026-03-25 09:46:38", "description": "" }, { "title": "Markets Rally, But Centenial Surgical Suture Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/centenial-surgical-suture-ltd-falls-to-52-week-low-of-rs-8028-3910615", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CentenialSurgic_priceRelatedfactors_3910615.png", "date": "2026-03-24 13:40:54", "description": "Despite a broadly positive market environment, Centenial Surgical Suture Ltd has fallen sharply to a new 52-week low of Rs 80.28 on 24 Mar 2026, marking a significant divergence from sector gains and broader indices." }, { "title": "Markets Rally, But Centenial Surgical Suture Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/centenial-surgical-suture-ltd-falls-to-52-week-low-amid-market-downturn-3907912", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CentenialSurgic_priceRelatedfactors_3907912.png", "date": "2026-03-23 12:52:16", "description": "" }, { "title": "Centenial Surgical Suture Ltd Surges 20.49%: Key Financial Turnaround and Technical Shifts", "link": "https://www.marketsmojo.com/news/stocks-in-action/centenial-surgical-suture-ltd-surges-2049-key-financial-turnaround-and-technical-shifts-3841112", "imagepath": "", "date": "2026-02-15 14:01:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>09 Feb:</strong> Stock opens at Rs.88.75, up 2.60% amid cautious market sentiment</p>\n <p><strong>10 Feb:</strong> Downgrade to Strong Sell announced, yet stock gains 1.18%</p>\n <p><strong>12 Feb:</strong> Technical upgrade to Sell rating announced, stock rises 3.45%</p>\n <p><strong>13 Feb:</strong> Positive Q4 2025 results reported, stock closes at Rs.104.22 (+6.35%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.86.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\"..." }, { "title": "Are Centenial Surgical Suture Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-centenial-surgical-suture-ltd-latest-results-good-or-bad-3840404", "imagepath": "", "date": "2026-02-14 19:45:36", "description": "Centenial Surgical Suture Ltd's latest financial results for Q3 FY26 indicate a notable shift in performance, with the company reporting a net profit of ₹0.15 crores, a significant turnaround from a loss of ₹0.85 crores in the same quarter last year. This marks a positive development after a challenging fiscal year 2025, where the company faced substantial losses. The revenue for the quarter also demonstrated strong momentum, growing by 21.80% year-on-year to ₹14.86 crores, which is the highest quarterly revenue in recent periods. Additionally, the operating margin improved to 10.30%, reflecting better operational efficiency and cost control.\n\nHowever, despite these positive headline figures, underlying challenges persist. The company has a five-year EBIT growth rate of -21.26%, indicating a long-term decline in operating profitability. Furthermore, the return on equity (ROE) remains negative at -6.78%, sug..." }, { "title": "Centenial Surgical Suture Ltd Reports Positive Financial Turnaround in Q4 2025", "link": "https://www.marketsmojo.com/news/stocks-in-action/centenial-surgical-suture-ltd-reports-positive-financial-turnaround-in-q4-2025-3837736", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CentenialSurgic_fintrenddot_3837736.png", "date": "2026-02-13 15:00:07", "description": "Centenial Surgical Suture Ltd has demonstrated a notable turnaround in its financial performance for the quarter ended December 2025, shifting from a flat to a positive growth trajectory. Despite lingering challenges in return metrics, the company’s latest quarterly results reveal encouraging signs of revenue expansion and profitability improvements, positioning it cautiously ahead in the competitive healthcare services sector." }, { "title": "Centenial Surgical Suture Q3 FY26: Return to Profitability Masks Deeper Structural Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/centenial-surgical-suture-q3-fy26-return-to-profitability-masks-deeper-structural-concerns-3838589", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CentenialSurgic_quaterlyResult_3838589.png", "date": "2026-02-13 12:03:16", "description": "Centenial Surgical Suture Ltd., a micro-cap surgical suture manufacturer with a market capitalisation of ₹36.00 crores, reported a return to profitability in Q3 FY26 with net profit of ₹0.15 crores, a sharp reversal from the ₹0.85 crores loss recorded in the corresponding quarter last year. However, the stock's 3.06% gain to ₹101.00 on February 13, 2026, following the results, belies deeper structural challenges that continue to plague the company's financial health and long-term growth prospects." }, { "title": "Centenial Surgical Suture Ltd Upgraded to Sell on Technical Improvement and Valuation Appeal", "link": "https://www.marketsmojo.com/news/stock-recommendation/centenial-surgical-suture-ltd-upgraded-to-sell-on-technical-improvement-and-valuation-appeal-3836716", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CentenialSurgic_mojoScore_3836716.png", "date": "2026-02-13 08:12:14", "description": "Centenial Surgical Suture Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 Feb 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The healthcare services company’s Mojo Score improved to 31.0, reflecting a modest recovery in market sentiment, though its financial and valuation metrics continue to signal caution for investors." } ], "total": 186, "sid": "191360", "stock_news_url": "https://www.marketsmojo.com/news/centenial-surgical-suture-191360" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "27-Mar-2026", "details": "PFA", "source": "BSE" }, { "caption": "Clarification On Price Movement", "datetime": "17-Mar-2026", "details": "PFA", "source": "BSE" }, { "caption": "Clarification sought from Centenial Surgical Suture Ltd", "datetime": "13-Mar-2026", "details": "The Exchange has sought clarification from Centenial Surgical Suture Ltd on March 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

09 Feb: Stock opens at Rs.88.75, up 2.60% amid cautious market sentiment

10 Feb: Downgrade to Strong Sell announced, yet stock gains 1.18%

12 Feb: Technical upgrade to Sell rating announced, stock rises 3.45%

13 Feb: Positive Q4 2025 results reported, stock closes at Rs.104.22 (+6.35%)

Week Open

Rs.86.50

Read full news article

Are Centenial Surgical Suture Ltd latest results good or bad?

2026-02-14 19:45:36

Centenial Surgical Suture Ltd's latest financial results for Q3 FY26 indicate a notable shift in performance, with the company reporting a net profit of ₹0.15 crores, a significant turnaround from a loss of ₹0.85 crores in the same quarter last year. This marks a positive development after a challenging fiscal year 2025, where the company faced substantial losses. The revenue for the quarter also demonstrated strong momentum, growing by 21.80% year-on-year to ₹14.86 crores, which is the highest quarterly revenue in recent periods. Additionally, the operating margin improved to 10.30%, reflecting better operational efficiency and cost control. However, despite these positive headline figures, underlying challenges persist. The company has a five-year EBIT growth rate of -21.26%, indicating a long-term decline in operating profitability. Furthermore, the return on equity (ROE) remains negative at -6.78%, sug...

Read full news article

Centenial Surgical Suture Ltd Reports Positive Financial Turnaround in Q4 2025

2026-02-13 15:00:07

Centenial Surgical Suture Ltd has demonstrated a notable turnaround in its financial performance for the quarter ended December 2025, shifting from a flat to a positive growth trajectory. Despite lingering challenges in return metrics, the company’s latest quarterly results reveal encouraging signs of revenue expansion and profitability improvements, positioning it cautiously ahead in the competitive healthcare services sector.

Read full news article

Centenial Surgical Suture Q3 FY26: Return to Profitability Masks Deeper Structural Concerns

2026-02-13 12:03:16

Centenial Surgical Suture Ltd., a micro-cap surgical suture manufacturer with a market capitalisation of ₹36.00 crores, reported a return to profitability in Q3 FY26 with net profit of ₹0.15 crores, a sharp reversal from the ₹0.85 crores loss recorded in the corresponding quarter last year. However, the stock's 3.06% gain to ₹101.00 on February 13, 2026, following the results, belies deeper structural challenges that continue to plague the company's financial health and long-term growth prospects.

Read full news article

Centenial Surgical Suture Ltd Upgraded to Sell on Technical Improvement and Valuation Appeal

2026-02-13 08:12:14

Centenial Surgical Suture Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 Feb 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The healthcare services company’s Mojo Score improved to 31.0, reflecting a modest recovery in market sentiment, though its financial and valuation metrics continue to signal caution for investors.

Read full news article